Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.
Stares M, Ding TE, Stratton C, Thomson F, Baxter M, Cagney H, Cumming K, Swan A, Ross F, Barrie C, Maclennan K, Campbell S, Evans T, Tufail A, Harrow S, Lord H, Laird B, MacKean M, Phillips I.
Stares M, et al. Among authors: baxter m.
ESMO Open. 2022 Apr;7(2):100445. doi: 10.1016/j.esmoop.2022.100445. Epub 2022 Apr 7.
ESMO Open. 2022.
PMID: 35398717
Free PMC article.